Mohnke Katja, Conzelmann Philipp, Renz Miriam, Riedel Julian, Rissel René, Urmann Andrea, Hain Johanna, Duenges Bastian, Ziebart Alexander, Ruemmler Robert
Department of Anesthesiology, Medical Center of Johannes Gutenberg University, Langenbeckstrasse 1, 55131, Mainz, Germany.
Intensive Care Med Exp. 2023 Nov 25;11(1):81. doi: 10.1186/s40635-023-00568-6.
This study aimed to determine whether ultra-low tidal volume ventilation (ULTVV) applied during cardiopulmonary resuscitation (CPR) compared with standard ventilation (intermittent positive pressure ventilation, IPPV) can reduce pulmonary end-organ damage in the post-resuscitation period.
A prospective, randomized trial was conducted using a porcine model (n = 45). The animals were divided into three groups: IPPV, ULTVV, and a sham control group. Juvenile male pigs underwent CPR after inducing ventricular fibrillation and received the designated ventilation intervention [IPPV: tidal volume 6-8 ml per kilogram body weight (ml/kg BW), respiratory rate 10/min, FiO 1.0; ULTVV: tidal volume 2-3 ml/kg BW, respiratory rate 50/min, FiO 1.0]. A 20-h observation period followed if return of spontaneous circulation was achieved. Histopathological examination using the diffuse alveolar damage scoring system was performed on postmortem lung tissue samples. Arterial and venous blood gas analyses and ventilation/perfusion measurements via multiple inert gas elimination technique (MIGET) were repeatedly recorded during the experiment.
Out of the 45 experiments conducted, 28 animals were excluded based on predefined criteria. Histopathological analysis showed no significant differences in lung damage between the ULTVV and IPPV groups. ULTVV demonstrated adequate oxygenation and decarboxylation. MIGET measurements during and after resuscitation revealed no significant differences between the intervention groups.
In the short-term follow-up phase, ULTVV demonstrated similar histopathological changes and functional pulmonary parameters compared to standard ventilation. Further research is needed to investigate the long-term effects and clinical implications of ULTVV in resuscitation settings.
本研究旨在确定在心肺复苏(CPR)期间应用的超低潮气量通气(ULTVV)与标准通气(间歇正压通气,IPPV)相比,是否能减少复苏后时期肺部终末器官损伤。
使用猪模型(n = 45)进行了一项前瞻性随机试验。动物被分为三组:IPPV组、ULTVV组和假手术对照组。幼年雄性猪在诱发心室颤动后接受心肺复苏,并接受指定的通气干预[IPPV:潮气量6 - 8毫升/千克体重(ml/kg BW),呼吸频率10次/分钟,吸入氧浓度1.0;ULTVV:潮气量2 - 3 ml/kg BW,呼吸频率50次/分钟,吸入氧浓度1.0]。如果实现自主循环恢复,则进行20小时的观察期。对死后肺组织样本进行使用弥漫性肺泡损伤评分系统的组织病理学检查。在实验期间反复记录动脉和静脉血气分析以及通过多惰性气体消除技术(MIGET)进行的通气/灌注测量。
在进行的45次实验中,根据预定义标准排除了28只动物。组织病理学分析显示ULTVV组和IPPV组之间的肺损伤无显著差异。ULTVV显示出足够的氧合和脱羧作用。复苏期间及之后的MIGET测量显示干预组之间无显著差异。
在短期随访阶段,与标准通气相比,ULTVV显示出相似的组织病理学变化和肺功能参数。需要进一步研究来探讨ULTVV在复苏环境中的长期影响和临床意义。